These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19330019)

  • 1. Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells.
    Chen LC; Liu HP; Li HP; Hsueh C; Yu JS; Liang CL; Chang YS
    Oncogene; 2009 Apr; 28(17):1904-15. PubMed ID: 19330019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma.
    Chen LC; Hsueh C; Tsang NM; Liang Y; Chang KP; Hao SP; Yu JS; Chang YS
    Clin Cancer Res; 2008 Jun; 14(12):3807-13. PubMed ID: 18559600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma.
    Wu CS; Chang KP; Chen LC; Chen CC; Liang Y; Hseuh C; Chang YS
    Oral Oncol; 2012 Jun; 48(6):516-22. PubMed ID: 22321252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation.
    Habelhah H; Shah K; Huang L; Ostareck-Lederer A; Burlingame AL; Shokat KM; Hentze MW; Ronai Z
    Nat Cell Biol; 2001 Mar; 3(3):325-30. PubMed ID: 11231586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization and downregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K) upon inhibition of mitogen/extracellular signal-regulated kinase (MEK) in malignant melanoma cells.
    Eder S; Lamkowski A; Priller M; Port M; Steinestel K
    Oncotarget; 2015 Jul; 6(19):17178-91. PubMed ID: 26136337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients.
    Chen LC; Chung IC; Hsueh C; Tsang NM; Chi LM; Liang Y; Chen CC; Wang LJ; Chang YS
    Cell Death Differ; 2010 Sep; 17(9):1463-73. PubMed ID: 20224598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma.
    Chung IC; Chen LC; Chung AK; Chao M; Huang HY; Hsueh C; Tsang NM; Chang KP; Liang Y; Li HP; Chang YS
    BMC Cancer; 2014 May; 14():348. PubMed ID: 24885469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53.
    Zhou R; Shanas R; Nelson MA; Bhattacharyya A; Shi J
    Int J Cancer; 2010 Jan; 126(2):395-404. PubMed ID: 19609950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells.
    Otoshi T; Tanaka T; Morimoto K; Nakatani T
    PLoS One; 2015; 10(12):e0145769. PubMed ID: 26713736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher expression of the heterogeneous nuclear ribonucleoprotein k in melanoma.
    Wen F; Shen A; Shanas R; Bhattacharyya A; Lian F; Hostetter G; Shi J
    Ann Surg Oncol; 2010 Oct; 17(10):2619-27. PubMed ID: 20499280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-kappaB and p38 MAPK pathways.
    Chen CC; Chen LC; Liang Y; Tsang NM; Chang YS
    Cell Signal; 2010 Jul; 22(7):1132-42. PubMed ID: 20214978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation.
    Yano M; Okano HJ; Okano H
    J Biol Chem; 2005 Apr; 280(13):12690-9. PubMed ID: 15671036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of heterogeneous nuclear ribonucleoprotein K gene expression.
    He L; Xue X; Wang Z; Hou E; Liu Y; Liang M; Zhang Y; Tian Z
    Biochimie; 2015 Feb; 109():27-35. PubMed ID: 25497182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression.
    Barboro P; Ferrari N; Balbi C
    Cancer Lett; 2014 Oct; 352(2):152-9. PubMed ID: 25016060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compartmentalization of hnRNP-K during cell cycle progression and its interaction with calponin in the cytoplasm.
    Laury-Kleintop LD; Tresini M; Hammond O
    J Cell Biochem; 2005 Aug; 95(5):1042-56. PubMed ID: 15962305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, phosphorylation, and mRNA-binding of heterogeneous nuclear ribonucleoprotein K in Xenopus oocytes, eggs, and early embryos.
    Iwasaki T; Koretomo Y; Fukuda T; Paronetto MP; Sette C; Fukami Y; Sato K
    Dev Growth Differ; 2008 Jan; 50(1):23-40. PubMed ID: 18042150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of heterogeneous nuclear ribonucleoprotein K in tumor development.
    Chen Y; Zeng Y; Xiao Z; Chen S; Li Y; Zou J; Zeng X
    J Cell Biochem; 2019 Sep; 120(9):14296-14305. PubMed ID: 31127648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct recruitment of ERK cascade components to inducible genes is regulated by heterogeneous nuclear ribonucleoprotein (hnRNP) K.
    Mikula M; Bomsztyk K
    J Biol Chem; 2011 Mar; 286(11):9763-75. PubMed ID: 21233203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression levels of hnRNP K and p21WAF1/CIP1 are associated with resistance to radiochemotherapy independent of p53 pathway activation in rectal adenocarcinoma.
    Daskalaki W; Wardelmann E; Port M; Stock K; Steinestel J; Huss S; Sperveslage J; Steinestel K; Eder S
    Int J Mol Med; 2018 Dec; 42(6):3269-3277. PubMed ID: 30272263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells.
    Zhu GH; Lenzi M; Schwartz EL
    Oncogene; 2002 Dec; 21(55):8477-85. PubMed ID: 12466967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.